Literature DB >> 21483646

Pre-clinical mouse models of human prostate cancer and their utility in drug discovery.

Serk In Park1, Sun Jin Kim, Laurie K McCauley, Gary E Gallick.   

Abstract

In vivo animal experiments are essential to current prostate cancer research, and are particularly critical to studying interactions between tumor cells and their microenvironment. Numerous pre-clinical animal models of prostate cancer are currently available, including transgenic mouse models and human prostate cancer xenograft mouse models. In contrast to transgenic mouse models producing more heterogeneous cohorts of tumors, xenograft mouse models provide more controlled approaches. This unit describes the detailed procedures necessary to establish several distinct pre-clinical mouse models of human prostate cancer, including an orthotopic prostate xenograft model, an orthotopic bone metastasis model, an experimental metastasis model of intra-cardiac injection, and a vossicle model of tumor-bone interaction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21483646      PMCID: PMC3072580          DOI: 10.1002/0471141755.ph1415s51

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  54 in total

1.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Authors:  L Bubendorf; A Schöpfer; U Wagner; G Sauter; H Moch; N Willi; T C Gasser; M J Mihatsch
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  Response and determinants of sensitivity to paclitaxel in human non-small cell lung cancer tumors heterotransplanted in nude mice.

Authors:  R Perez-Soler; B Kemp; Q P Wu; L Mao; J Gomez; A Zeleniuch-Jacquotte; H Yee; J S Lee; J Jagirdar; Y H Ling
Journal:  Clin Cancer Res       Date:  2000-12       Impact factor: 12.531

3.  Rapid ("warm") autopsy study for procurement of metastatic prostate cancer.

Authors:  M A Rubin; M Putzi; N Mucci; D C Smith; K Wojno; S Korenchuk; K J Pienta
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

Review 4.  Autochthonous mouse models for prostate cancer: past, present and future.

Authors:  W J Huss; L A Maddison; N M Greenberg
Journal:  Semin Cancer Biol       Date:  2001-06       Impact factor: 15.707

5.  Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis.

Authors:  Minjung J Kim; Rajula Bhatia-Gaur; Whitney A Banach-Petrosky; Nishita Desai; Yuzhuo Wang; Simon W Hayward; Gerald R Cunha; Robert D Cardiff; Michael M Shen; Cory Abate-Shen
Journal:  Cancer Res       Date:  2002-06-01       Impact factor: 12.701

Review 6.  Mouse models of prostate carcinogenesis.

Authors:  Cory Abate-Shen; Michael M Shen
Journal:  Trends Genet       Date:  2002-05       Impact factor: 11.639

7.  Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases.

Authors:  Hisanori Uehara; Sun Jin Kim; Takashi Karashima; David L Shepherd; Dominic Fan; Rachel Tsan; Jerald J Killion; Christopher Logothetis; Paul Mathew; Isaiah J Fidler
Journal:  J Natl Cancer Inst       Date:  2003-03-19       Impact factor: 13.506

8.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.

Authors:  Isaiah J Fidler
Journal:  Nat Rev Cancer       Date:  2003-06       Impact factor: 60.716

9.  Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model.

Authors:  Paula J Kaplan-Lefko; Tsuey-Ming Chen; Michael M Ittmann; Roberto J Barrios; Gustavo E Ayala; Wendy J Huss; Lisette A Maddison; Barbara A Foster; Norman M Greenberg
Journal:  Prostate       Date:  2003-05-15       Impact factor: 4.104

10.  Blockade of epidermal growth factor receptor signaling in tumor cells and tumor-associated endothelial cells for therapy of androgen-independent human prostate cancer growing in the bone of nude mice.

Authors:  Sun-Jin Kim; Hisanori Uehara; Takashi Karashima; David L Shepherd; Jerald J Killion; Isaiah J Fidler
Journal:  Clin Cancer Res       Date:  2003-03       Impact factor: 12.531

View more
  43 in total

1.  Intratibial injection of patient-derived tumor cells from giant cell tumor of bone elicits osteolytic reaction in nude mouse.

Authors:  Leqin Xu; Zhipeng Wu; Zhenhua Zhou; Xinghai Yang; Jianru Xiao
Journal:  Oncol Lett       Date:  2018-07-16       Impact factor: 2.967

Review 2.  The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.

Authors:  Ulrich H Weidle; Alexandra Epp; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2019 Jan-Feb       Impact factor: 4.069

3.  ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.

Authors:  Amanda G Hansen; Shanna A Arnold; Ming Jiang; Trenis D Palmer; Tatiana Ketova; Alyssa Merkel; Michael Pickup; Susan Samaras; Yu Shyr; Harold L Moses; Simon W Hayward; Julie A Sterling; Andries Zijlstra
Journal:  Cancer Res       Date:  2014-01-02       Impact factor: 12.701

4.  Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cells.

Authors:  Serk In Park; Laurie K McCauley
Journal:  Endocr Relat Cancer       Date:  2012-05-03       Impact factor: 5.678

5.  Parathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth.

Authors:  Serk In Park; Changki Lee; W David Sadler; Amy J Koh; Jacqueline Jones; Jung Won Seo; Fabiana N Soki; Sun Wook Cho; Stephanie D Daignault; Laurie K McCauley
Journal:  Cancer Res       Date:  2013-09-26       Impact factor: 12.701

Review 6.  Drug discovery in prostate cancer mouse models.

Authors:  Kenneth C Valkenburg; Kenneth J Pienta
Journal:  Expert Opin Drug Discov       Date:  2015-06-01       Impact factor: 6.098

7.  Tumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.

Authors:  J L Werbeck; N K Thudi; C K Martin; C Premanandan; L Yu; M C Ostrowksi; T J Rosol
Journal:  Vet Pathol       Date:  2013-10-03       Impact factor: 2.221

8.  Prevalence of prostate cancer metastases after intravenous inoculation provides clues into the molecular basis of dormancy in the bone marrow microenvironment.

Authors:  Younghun Jung; Yusuke Shiozawa; Jingcheng Wang; Natalie McGregor; Jinlu Dai; Serk In Park; Janice E Berry; Aaron M Havens; Jeena Joseph; Jin Koo Kim; Lalit Patel; Peter Carmeliet; Stephanie Daignault; Evan T Keller; Laurie K McCauley; Kenneth J Pienta; Russell S Taichman
Journal:  Neoplasia       Date:  2012-05       Impact factor: 5.715

9.  Inhibition of bone loss with surface-modulated, drug-loaded nanoparticles in an intraosseous model of prostate cancer.

Authors:  Isaac M Adjei; Blanka Sharma; Chiranjeevi Peetla; Vinod Labhasetwar
Journal:  J Control Release       Date:  2016-04-15       Impact factor: 9.776

10.  Prioritizing cancer therapeutic small molecules by integrating multiple OMICS datasets.

Authors:  Sali Lv; Yanjun Xu; Xin Chen; Yan Li; Ronghong Li; Qianghu Wang; Xia Li; Bin Su
Journal:  OMICS       Date:  2012-08-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.